Does CBD Have Any Antiseptic Properties?

The relationship in between infection and conventional antibiotics

Could CBD work in the battle versus resistant bacterial stress? The results from the University of Queensland in Australia recommend that it is possible. But before examining the study in depth, it works to comprehend the advancement of the relationship in between bacteria and antibiotics.

Since the innovative discovery of penicillin by Alexander Fleming in 1928, antibiotics have actually been an important tool in the battle versus bacteria and infections. And although we still use the same proven methods today, bacteria have actually progressed. When exposed to antibiotics, certain bacteria, fungis and parasites are able to adjust and cancel the effectiveness of the drug by developing resistance.

It’s worth mentioning that antimicrobial resistance was likely to happen anyhow, as the genetic code for bacteria modifications with time. However, it is thought that the overuse of antibiotics is a crucial factor that speeds up the development of resistant stress.

According to the World Health Organization, antimicrobial resistance “is an increasingly major danger to global public health that needs action in all sectors of federal government and in society.” This has led scientists to think outside package by attempting to recognize substances that could be helpful in the battle versus hazardous bacteria. Among these substances is cannabidiol (CBD), a cannabinoid found in Cannabis sativa.

Scientists are trying to find new ways to assault infections and resistant bacteria.

Dr. Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery and Senior Research Officer at the Institute for Molecular Bioscience at the University of Queensland, concluded that CBD is effective versus Gram-positive bacteria. Pressures of Gram-positive bacteria consist of Staphylococcus aureus (common in skin infections) and Streptococcus pneumoniae (common in bacterial pneumonia).

Dr. Blaskovich presented his findings at an annual conference of the American Society for Microbiology. In vitro samples of both types of gram-positive bacteria were treated with artificial CBD. The outcomes led Dr. Blaskovich to the conclusion that CBD works at levels similar to those of prescription antibiotics vancomycin and daptomycin. He also found that CBD appeared to work against gram-positive stress of resistant bacteria, which numerous traditional antibiotics are beginning to stop working.

” In particular, the activity was chosen versus the resistant stress of Staphylococcus aureus (MRSA, VISA, SARV), Streptococcus pneumoniae (MDR), and Enterococcus faecalis (ERV). Cannabidiol was bactericidal, had a low propensity to cause resistance and was active versus MRSA biofilms. “

The group also conducted another study using topical CBD to treat a skin infection in mice. Again, although the outcomes were positive, CBD did not appear to remove the infection, however just to minimize the number of bacterial cells.

Could CBD become an antibiotic?

While it is simple to hail this work as a substantial advancement in the antibacterial capabilities of CBD, it is too soon to give up on penicillin.

Although it is thought that the effectiveness of CBD could originate from the method it assaults the biofilm surrounding bacterial cells, the authors are still unsure of the system of action of CBD. They also did not hesitate to explain the shortcomings of the study. Dr. Blaskovich explained that given that the outcomes remain in the preliminary phases, it is far prematurely for individuals to start treating their CBD infections themselves.

The study was also conducted in vitro (outside the human body), and there is a threat that the outcomes of medical trials will not be the same. Several substances have actually shown antibacterial effectiveness in petri meals, however then failed at this crucial phase. It should also be pointed out that the two research studies were carried out in collaboration with Botanix Pharmaceuticals Ltd, a pharmaceutical company specializing in topical CBD products.

However, this research study could be a crucial advance for CBD and the battle versus antimicrobial resistance. CBD continues to have an excellent safety profile and is ruled out poisonous even in big amounts. Luckily, Dr. Blaskovich and his group plan to continue their research study. If you would like to read more on the subject I would advise reading both Spectral CBD and CBD Topia.

Scroll to top